{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-038072","form_type":"8-K","ticker":"PAVM","cik":"0001624326","company_name":"PAVmed Inc.","filed_at":"2026-08-14T14:44:53+00:00","discovered_at":"2026-08-14T14:45:31.423779+00:00","generated_at":"2026-08-14T14:45:38.283664+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"PAVmed Q2 2026 net loss $5.5M; Lucid EsoGuard revenue $1.5M, cash up to $3.8M","bullets":["Q2 2026 GAAP net loss ~$5.5M ($0.87/diluted share); non-GAAP adjusted net loss ~$1.7M ($0.27/share).","Cash and equivalents $3.8M at June 30, 2026, up from $1.5M at Dec 31, 2025; operating expenses ~$7.1M.","Lucid Diagnostics (LUCD) posted $1.5M EsoGuard revenue in 2Q26, 2,770 tests; secured first lab benefit manager coverage policy.","Veris Health accelerated commercial engagement with OSU-The James; implantable monitor on track for early 2027 FDA 510(k) submission.","PortIO first-in-human data published in Journal of Vascular Access: 100% patency, 90% intended implant duration completion, no device-related adverse events."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-038072","json":"https://secwatch.observer/filing/0001493152-26-038072.json","markdown":"https://secwatch.observer/filing/0001493152-26-038072.md","text":"https://secwatch.observer/filing/0001493152-26-038072.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1624326/000149315226038072/0001493152-26-038072-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1624326/000149315226038072/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-14T14:45:38.283664+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}